The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop
- PMID: 19617843
- PMCID: PMC2936269
- DOI: 10.1097/GIM.0b013e3181b13a6c
The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop
Abstract
The increasing availability of personal genomic tests has led to discussions about the validity and utility of such tests and the balance of benefits and harms. A multidisciplinary workshop was convened by the National Institutes of Health and the Centers for Disease Control and Prevention to review the scientific foundation for using personal genomics in risk assessment and disease prevention and to develop recommendations for targeted research. The clinical validity and utility of personal genomics is a moving target with rapidly developing discoveries but little translation research to close the gap between discoveries and health impact. Workshop participants made recommendations in five domains: (1) developing and applying scientific standards for assessing personal genomic tests; (2) developing and applying a multidisciplinary research agenda, including observational studies and clinical trials to fill knowledge gaps in clinical validity and utility; (3) enhancing credible knowledge synthesis and information dissemination to clinicians and consumers; (4) linking scientific findings to evidence-based recommendations for use of personal genomics; and (5) assessing how the concept of personal utility can affect health benefits, costs, and risks by developing appropriate metrics for evaluation. To fulfill the promise of personal genomics, a rigorous multidisciplinary research agenda is needed.
Conflict of interest statement
Disclosure: Several authors have varying conflicts of interest because of employment and other affiliations. See complete list in the Acknowledgments section
Similar articles
-
The genomic applications in practice and prevention network.Genet Med. 2009 Jul;11(7):488-94. doi: 10.1097/GIM.0b013e3181a551cc. Genet Med. 2009. PMID: 19471162 Free PMC article.
-
Evaluating the utility of personal genomic information.Genet Med. 2009 Aug;11(8):570-4. doi: 10.1097/GIM.0b013e3181a2743e. Genet Med. 2009. PMID: 19478683
-
Personal utility and genomic information: look before you leap.Genet Med. 2009 Aug;11(8):575-6. doi: 10.1097/GIM.0b013e3181af0a80. Genet Med. 2009. PMID: 19623080 Free PMC article. No abstract available.
-
National Institutes of Health Pathways to Prevention Workshop: Research Gaps for Long-Term Drug Therapies for Osteoporotic Fracture Prevention.Ann Intern Med. 2019 Jul 2;171(1):51-57. doi: 10.7326/M19-0961. Epub 2019 Apr 23. Ann Intern Med. 2019. PMID: 31009943
-
Libraries and genomics: providing support to health care providers and consumers.Mo Med. 2014 Sep-Oct;111(5):408-12. Mo Med. 2014. PMID: 25438361 Free PMC article. Review. No abstract available.
Cited by
-
Perspectives on pharmacogenomics of antiretroviral medications and HIV-associated comorbidities.Curr Opin HIV AIDS. 2015 Mar;10(2):116-22. doi: 10.1097/COH.0000000000000134. Curr Opin HIV AIDS. 2015. PMID: 25565175 Free PMC article. Review.
-
Genetic testing behavior and reporting patterns in electronic medical records for physicians trained in a primary care specialty or subspecialty.J Am Med Inform Assoc. 2012 Jul-Aug;19(4):570-4. doi: 10.1136/amiajnl-2011-000621. Epub 2012 Apr 17. J Am Med Inform Assoc. 2012. PMID: 22511017 Free PMC article.
-
A survey of UK public interest in internet-based personal genome testing.PLoS One. 2010 Oct 19;5(10):e13473. doi: 10.1371/journal.pone.0013473. PLoS One. 2010. PMID: 20976053 Free PMC article.
-
Evaluation of a decision aid for incidental genomic results, the Genomics ADvISER: protocol for a mixed methods randomised controlled trial.BMJ Open. 2018 Apr 26;8(4):e021876. doi: 10.1136/bmjopen-2018-021876. BMJ Open. 2018. PMID: 29700101 Free PMC article.
-
Review of the Reported Measures of Clinical Validity and Clinical Utility as Arguments for the Implementation of Pharmacogenetic Testing: A Case Study of Statin-Induced Muscle Toxicity.Front Pharmacol. 2017 Aug 23;8:555. doi: 10.3389/fphar.2017.00555. eCollection 2017. Front Pharmacol. 2017. PMID: 28878673 Free PMC article. Review.
References
-
- Feero WG, Guttmacher AE, Collins FS. The genome gets personal, almost. JAMA. 2008;299:1351–1352. - PubMed
-
- Offit K. Genomic profiles for disease risk: predictive or premature? JAMA. 2008;299:1353–1355. - PubMed
-
- Hunter DJ, Khoury MJ, Drazen JM. Letting the genome out of the bottle: will we get our wish? N Engl J Med. 2008;358:105–107. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous